Skip to content
lifestyle.thenyctimes.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
ExCellThera
Zemcelpro® (UM171 Cell Therapy) licensing and supply agreements announced for Canada
June 10, 2026
Zemcelpro® (dorocubicel) Positive Results in High- and Very High-Risk Blood Cancers to be Reported at the EBMT 2026 Annual Meeting
March 10, 2026
Zemcelpro® (dorocubicel) receives NUB Status 1 in Germany
February 16, 2026